Thomas R. Kosten Professor of Psychiatry |
||
Biography | ||
Following a successful 25-year tenure as Professor and Chief of Psychiatry at Yale University and Veteran Affairs Connecticut, Dr. Kosten joined the Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC) in July 2006, bringing over 30 years of exemplary Federal service, the majority of which has been with the Department of Veterans Affairs (VA). Over the period from 2006-2011, Dr. Kosten served as the Research Director of the VA National. With a joint appointment at Baylor College of Medicine (BCM), Dr. Kosten is the JH Waggoner Chair & Professor of Psychiatry, Pharmacology, Neuroscience and Immunology and Pathology. He is also vice-Chair for Psychiatry and Codirector of the Dan L. Duncan Institute for Clinical and Translational Research at Baylor College of Medicine. His other key appointments are Distinguished Professor of Psychiatry at Peking University Medical School and Professor of Epidemiology and of Behavioral Sciences at MD Anderson Cancer Prevention Center. He established the Division of Addictions Psychiatry at Baylor and Yale and directs their National Institute of Health (NIH) Medications Development Center for substance abuse. A recognized leader in clinical and translational sciences, Dr. Kosten is a past recipient of a NIH Research Scientist Award (1987-2010). He has served on national and international review groups for medications and vaccines development in substance abuse, and is credited with the development of several cutting-edge discoveries in medications for addictions.Dr. Kosten’s recent work includes serving on the National Academy of Sciences, Institute of Medicine (IOM) Committee on Vaccines for Substance Abuse. He also served on the recently concluded IOM’s Committee on Prevention, Diagnosis, Treatment, and Management of Substance Use Disorders in the US Armed Forces, a congressional mandate via the National Defense Authorization Act for Fiscal Year 2010 (Public Law 111-84) to conduct an independent study on substance use disorders in the military. Additionally, he continues to serve on various US Food and Drug Administration panels for medication approvals in psychiatry and analgesics. |
||
Research Interest | ||
Developing medications & vaccines for addictions |
||
Global Experts in the subject | ||
Adriana Campa | Ahmed Haque | Bhopesh Thakur |
Bruce Davies | Carlos J. Rubinstein | Deena J Tampi |
Dikotlana Study Team | Glennon W Simmons | Herman Bussmann |
J Bryan Page | Jenna D. Moore-Liester | John T McDevitt |
Jorge Wong | Joseph Makhema | Julien S. Baker |
L Cecil Powell | Lesedi Tsalaile | Manju Kaundal |
Marianna K Baum | Michael P McRae | Michael R. Graham |
Mitchell B Liester | Moyo Sikhulele | Myron Essex |
Nicolaos Christodoulides | Oâââ‰â¢Dale Williams | Patricia Burns |
R Constance Wiener | Rajesh R Tampi | Rhonda Conerly Holliday |
Richard De La Garzall | Richard Marlink | Sabrina Sales Martinez |
Shenghan Lai | Silpa Chandran | Silvia Fare |
Sujan Barua | Thomas F Newton | Torrance Stephens |
Yinghui Li Erik van Widenfelt |